Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.18B | 13.99B | 16.82B | 6.96B | 3.60B | Gross Profit |
5.68B | 6.47B | 10.28B | 3.12B | 615.00M | EBIT |
6.30B | 5.74B | 8.34B | 3.33B | 102.00M | EBITDA |
9.50B | 8.70B | 10.41B | 4.12B | -3.32B | Net Income Common Stockholders |
3.57B | 1.66B | 6.50B | 1.98B | -4.03B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.11B | 1.95B | 6.88B | 3.35B | 3.78B | Total Assets |
61.26B | 55.36B | 59.32B | 26.47B | 24.62B | Total Debt |
11.62B | 6.50B | 6.45B | 6.61B | 7.40B | Net Debt |
7.70B | 4.76B | 247.00M | 3.58B | 3.79B | Total Liabilities |
25.11B | 20.19B | 22.19B | 12.24B | 11.75B | Stockholders Equity |
35.40B | 34.40B | 36.34B | 13.44B | 12.07B |
Cash Flow | Free Cash Flow | |||
945.00M | 854.00M | 5.67B | 1.17B | -96.00M | Operating Cash Flow |
5.85B | 6.14B | 8.81B | 3.79B | 1.85B | Investing Cash Flow |
-5.75B | -5.58B | -2.27B | -2.94B | -2.11B | Financing Cash Flow |
2.10B | -5.00B | -3.36B | -1.42B | -203.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $19.75B | 17.19 | 8.56% | 3.29% | -3.92% | -29.44% | |
75 Outperform | $19.67B | 6.65 | 21.77% | 4.12% | 3.00% | -21.63% | |
73 Outperform | $24.32B | 6.80 | 10.23% | 9.21% | -0.93% | 115.30% | |
68 Neutral | $37.94B | 8.31 | 12.20% | 4.51% | 31.55% | -9.00% | |
68 Neutral | $37.32B | 16.25 | 8.88% | 2.27% | -4.35% | -37.69% | |
67 Neutral | $29.66B | 110.78 | 1.30% | 1.24% | 3.00% | -90.88% | |
55 Neutral | $6.97B | 3.35 | -6.10% | 6.00% | -0.44% | -51.04% |